SEC Form 4 · accession 0001013606-16-000290
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph A. DeJohn
Officer — General Manager, Asia & Pac
Period of report
Jul 8, 2016
Accepted (ET)
Jul 11, 2016 · 10:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 8, 2016 | A | 28,944 | $0.00 | A | 157,847 | D | |
| Common StockF2 | Jul 8, 2016 | F | 4,376 | $13.76 | D | 153,471 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on October 2, 2012. 40% percent of the shares subject to this performance award vested upon the Company's achievement of a performance milestone on July 7, 2016.
- F2Shares sold on July 8, 2016 to satisfy statutory minimum tax withholding obligations related to Performance Stock Unit shares vested on July 7, 2016.